GTBP GT Biopharma Inc
Company Analysis
Latest News
🔴 GT Biopharma is trading 13% down with no clear catalyst
GT Biopharma is trading 12.86% lower at $6.37 on October 21, 2026; no clear company-specific catalyst has been identified. - The investor-relations page lists...
🔴 GT Biopharma is trading 7% down in pre-market
GT Biopharma is trading 6.98% lower at $6.80 pre-market versus the supplied previous close of $7.31; no clear company-specific catalyst was identified. - The...
🟢 GT Biopharma is trading 5.7% up — no clear catalyst identified
GT Biopharma is trading 5.7% higher at $7.07 on October 20, 2026, with no new company-specific announcement or clear catalyst identified for the move. - The...
🟢 GT Biopharma is trading 2.0% up in pre-market with no clear catalyst identified
GT Biopharma is trading in pre-market at $7.17, up 2.0%, with no clearly established catalyst. - The shares are above the October 16 close of $7.03. - No new...
🟢 GT Biopharma is trading 6.8% up in pre-market with no clear catalyst identified
GT Biopharma is trading at $7.51, up 6.8%, with no clear catalyst identified. - The price compares with the October 16 close of $7.03. - No new...
🔴 GT Biopharma is trading 6.25% down today amid a 2.06% drop in biotech ETF XBI
GT Biopharma is trading at $6.90, down 6.25%, amid pressure on small-cap biotech stocks, with biotech ETF XBI down 2.06%. - No new company-specific...
🟢 GT Biopharma is trading 16% up
GT Biopharma is trading at $7.21, up 16.10% on October 15, 2026; no new company-specific announcement explaining the gain was identified. - The earlier resale...
🟢 GT Biopharma is trading 7% up
GT Biopharma is trading 7.00% higher at $6.71 on October 15, 2026; no new company-specific announcement explaining the gain was identified. - A resale...
🟢 GT Biopharma is trading 6% up in pre-market with no identified company-specific explanation
GT Biopharma is trading 5.64% higher at $6.56 in pre-market, with no company-specific announcement identified to explain the move. - A resale registration for...
🔴 GT Biopharma is trading 6% down today with no confirmed specific catalyst
GT Biopharma is trading 6.15% lower at $6.10, with no confirmed company-specific announcement explaining the decline. - A report published October 14...
🔴 GT Biopharma is trading 5% down today with no confirmed company-specific explanation
GT Biopharma is trading 5.44% lower at $6.43; no company-specific announcement confirms a reason for the October 13 decline. - Latest investor-relations news...
🟢 GT Biopharma is trading 6% up with no confirmed catalyst
GT Biopharma is trading at $7.20, up 5.95%, as of 9:38 a.m. ET on October 13, 2026; no confirmed company-specific announcement explains the move. - The...
🟢 GT Biopharma is trading 5% up with no confirmed company-specific catalyst
GT Biopharma is trading at $7.02, up +5.02%, with no confirmed company-specific news explaining the move. - At 11:16 a.m. ET October 12, 2026, the official...
🟢 GT Biopharma is trading 5.79% up amid biotech-sector strength
GT Biopharma is trading 5.79% up at $6.30 on October 9, 2026, with no confirmed company-specific catalyst; broader biotech strength may be supporting shares. -...
🔴 GT Biopharma is trading 6.45% down amid biotech-sector weakness
GT Biopharma is trading at $5.80, down 6.45%, alongside biotech-sector weakness; no direct cause is confirmed. - XBI is down 2.04%. Broader risk-off...
🟢 GT Biopharma is trading 5% up in after-hours trading
GT Biopharma is trading 5.03% up at $6.47 in after-hours trading; no specific October 5 catalyst was identified. - The stock closed the regular session at...
🟢 GT Biopharma is trading 7.21% up
GT Biopharma is trading at $6.54, up 7.21%, with no specific cause for the gain established. - No clear company-specific catalyst for October 5 was...
🟢 GT Biopharma is trading 8.85% up in pre-market
GT Biopharma is trading at $6.64, up 8.85% in pre-market; no clear catalyst has been identified. - No new company-specific announcement for October 5 was...
🟢 GT Biopharma is trading 5.9% up in after-hours trading with no clear company-specific catalyst
GT Biopharma is trading at $6.46, up 5.90% from the October 2 regular-session close of $6.10, with no clear company-specific catalyst identified. - The...
🔴 GT Biopharma is trading 9.84% down in after-hours trading — catalyst remains unconfirmed
GT Biopharma is trading 9.84% down at $5.50 after-hours; the reason for the decline remains unconfirmed. - Shares closed at $6.10 on October 2, 2026, and...